Eleven Biotherapeutics Inc. (EBIO) Trading Down 5.9%
Eleven Biotherapeutics Inc. (NASDAQ:EBIO)’s share price traded down 5.9% during trading on Friday . The company traded as low as $3.80 and last traded at $4.11, with a volume of 3,013,986 shares traded. The stock had previously closed at $4.37.
The company’s market capitalization is $61.11 million. The company has a 50-day moving average price of $2.48 and a 200-day moving average price of $1.16.
In other news, major shareholder Boxer Capital, Llc sold 1,042,000 shares of the company’s stock in a transaction that occurred on Monday, June 13th. The stock was sold at an average price of $2.74, for a total transaction of $2,855,080.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Eleven Biotherapeutics, Inc is a clinical-stage biopharmaceutical company. The Company through AMP-Rx, a protein engineering platform, is engaged in the discovery and development of protein therapeutics to treat diseases of the eye. The Company designs, engineers and generates a pipeline of protein therapeutic candidates that target cytokines, which are central to diseases of the eye.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.